Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuroone Medical Technologies (NMTC) Current Assets (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Current Assets for 14 consecutive years, with $8.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 41.24% year-over-year to $8.1 million, compared with a TTM value of $8.1 million through Dec 2025, up 41.24%, and an annual FY2025 reading of $10.2 million, up 120.83% over the prior year.
  • Current Assets was $8.1 million for Q4 2025 at Neuroone Medical Technologies, down from $10.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $16.6 million in Q4 2021 and bottomed at $3.8 million in Q1 2025.
  • Average Current Assets over 5 years is $8.3 million, with a median of $7.7 million recorded in 2023.
  • The sharpest move saw Current Assets tumbled 55.36% in 2023, then soared 148.95% in 2025.
  • Year by year, Current Assets stood at $16.6 million in 2021, then plummeted by 45.9% to $9.0 million in 2022, then crashed by 43.2% to $5.1 million in 2023, then increased by 12.15% to $5.7 million in 2024, then soared by 41.24% to $8.1 million in 2025.
  • Business Quant data shows Current Assets for NMTC at $8.1 million in Q4 2025, $10.2 million in Q3 2025, and $10.2 million in Q2 2025.